Form 4 Filing for Klencke Barbara - ALX ONCOLOGY HOLDINGS INC

Barbara Klencke, Chief Medical Officer of ALX ONCOLOGY HOLDINGS INC, acquired 100,000 stock options on April 16, 2026. The options have an exercise price of $1.68 and expire on April 15, 2036. The options vest over time, with one-fourth vesting on February 25, 2027, and the remainder vesting monthly thereafter. This transaction is reported on Form 4, indicating a change in beneficial ownership.